Frédéric Maloisel

6.8k total citations
74 papers, 2.8k citations indexed

About

Frédéric Maloisel is a scholar working on Hematology, Genetics and Oncology. According to data from OpenAlex, Frédéric Maloisel has authored 74 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Hematology, 26 papers in Genetics and 26 papers in Oncology. Recurrent topics in Frédéric Maloisel's work include Chronic Lymphocytic Leukemia Research (24 papers), Chronic Myeloid Leukemia Treatments (20 papers) and Blood disorders and treatments (16 papers). Frédéric Maloisel is often cited by papers focused on Chronic Lymphocytic Leukemia Research (24 papers), Chronic Myeloid Leukemia Treatments (20 papers) and Blood disorders and treatments (16 papers). Frédéric Maloisel collaborates with scholars based in France, United States and Luxembourg. Frédéric Maloisel's co-authors include Emmanuel Andrès, Jean‐Luc Harousseau, Jacques Zimmer, Gérald Marit, Michel Attal, Mauricette Michallet, Denis Caillot, Jean Sibilia, Philippe Moreau and Thierry Façon and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Frédéric Maloisel

69 papers receiving 2.7k citations

Peers

Countries citing papers authored by Frédéric Maloisel

Since Specialization

Citations

This map shows the geographic impact of Frédéric Maloisel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frédéric Maloisel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frédéric Maloisel more than expected).

Fields of papers citing papers by Frédéric Maloisel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frédéric Maloisel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frédéric Maloisel. The network helps show where Frédéric Maloisel may publish in the future.

Co-authorship network of co-authors of Frédéric Maloisel

This figure shows the co-authorship network connecting the top 25 collaborators of Frédéric Maloisel. A scholar is included among the top collaborators of Frédéric Maloisel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frédéric Maloisel. Frédéric Maloisel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Artificial Intelligence (AI) and Drug-Induced and Idiosyncratic Cytopenia: The Role of AI in Prevention, Prediction, and Patient Participation 2025 ·Hematology Reports ·Emmanuel Andrès, Amir Hajjam El Hassani, Frédéric Maloisel, María Belén Alonso Ortiz, Manuel Méndez‐Bailón, Thierry Lavigne, (unknown), Noël Lorenzo-Villalba	0
2	Bosutinib for Patients with Previously Treated Chronic Myeloid Leukemia: Results from the French Observational Boseval Study 2024 ·Blood ·Philippe Rousselot, Jean‐Christophe Ianotto, Philippe Quittet, Maya Hacini, Gabrielle Roth-Guépin, (unknown), Frédéric Maloisel, Valérie Coiteux, Gabriel Étienne	0
3	Tuberculosis and atypical mycobacterial infections in ruxolitinib-treated patients with primary or secondary myelofibrosis or polycythemia vera 2019 ·International Journal of Infectious Diseases ·(unknown), Marie‐Pierre Ledoux, Simon Gravier, Shanti Natarajan‐Amé, (unknown), Frédéric Maloisel, Laurent Mauvieux, Elise Toussaint, Luc‐Matthieu Fornecker, Raoul Herbrecht	19
4	Idiosyncratic drug-induced neutropenia & agranulocytosis 2017 ·QJM ·Emmanuel Andrès, (unknown), Frédéric Maloisel, François Séverac, (unknown), Thomas Vogel, (unknown), Jean‐Christophe Weber, Georges Kaltenbach, Jacques‐Eric Gottenberg, Bernard Goichot, Jean Sibilia, Anne‐Sophie Korganow, Raoul Herbrecht	35
5	Rituximab therapy for hairy cell leukemia: a retrospective study of 41 cases 2014 ·Annals of Hematology ·Mathieu Leclerc, Felipe Suárez, Marie‐Pierre Noël, Anne Vekhoff, Xavier Troussard, (unknown), Catherine Thiéblemont, Frédéric Maloisel, Yves Béguin, Jérôme Tamburini, Coralie Barbe, Alain Delmer	15
6	Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemia 2014 ·Annals of Hematology ·Édouard Cornet, Alain Delmer, Pierre Feugier, Francine Garnache‐Ottou, David Ghez, Véronique Leblond, Vincent Lévy, Frédéric Maloisel, (unknown), Jean‐Marc Zini, Xavier Troussard	34
7	Study design: two long-term observational studies of the biosimilar filgrastim Nivestim™ (Hospira filgrastim) in the treatment and prevention of chemotherapy-induced neutropenia 2013 ·BMC Cancer ·(unknown), Stefan Früehauf, Frédéric Maloisel, L. Cals, Stéphane Leprêtre, Christian Berthou	8
8	Neutropénie de l’adulte et du sujet âgé 2008 ·Emmanuel Andrès, Thierry Weitten, Laure Fédérici, Mustapha Mecili, (unknown), Thomas Vogel, Frédéric Maloisel	1
9	High efficacy with five days schedule of oral fludarabine phosphate and cyclophosphamide in patients with previously untreated chronic lymphocytic leukaemia 2008 ·British Journal of Haematology ·Bruno Cazin, Marine Diviné, Stéphane Leprêtre, Philippe Travade, Olivier Tournilhac, Alain Delmer, J. Jaubert, Pierre Feugier, Brigitte Dreyfus, Beatrice Mahé, B. Grosbois, Frédéric Maloisel, Houchingue Eghbali, Charles Dumontet, Jacques Bénichou, (unknown), Xavier Leleu, M Leporrier, Karim Maloum	13
10	Agranulocytoses médicamenteuses idiosyncrasiques 2008 ·La Presse Médicale ·Laure Fédérici, Thierry Weitten, Martine Alt, Thomas Gille, Alina D. Zamfir, B. Audhuy, Frédéric Maloisel, Emmanuel Andrès	6
11	Clinical outcome of 27 imatinib mesylate-resistant chronic myelogenous leukemia patients harboring a T315I BCR-ABL mutation 2007 ·Haematologica ·Franck E. Nicolini, Sandrine Hayette, Sélim Corm, Emmanuel Bachy, Dominique Bories, Michel Tulliez, François Guilhot, Laurence Legros, Frédéric Maloisel, Jean‐Jacques Kiladjian, François‐Xavier Mahon, Quoc‐Hung Le, Mauricette Michallet, Catherine Roche‐Lestienne, Claude Preudhomme	51
12	Purpura thrombopénique idiopathique et grossesse : expérience personnelle et revue de la littérature 2006 ·Frédéric Maloisel, Laure Fédérici, (unknown), (unknown), Jacques Zimmer, Emmanuel Andrès	1
13	Traitement du purpura thrombopénique idiopathique de l’adulte : expérience personnelle et revue de la littérature 2005 ·Emmanuel Andrès, Jacques Zimmer, Stéphane Affenberger, (unknown), Frédéric Maloisel	0
14	Food-cobalamin malabsorption in elderly patients: Clinical manifestations and treatment 2005 ·The American Journal of Medicine ·Emmanuel Andrès, Stéphane Affenberger, S. Vinzio, Jean‐Emmanuel Kurtz, Esther Noël, Georges Kaltenbach, Frédéric Maloisel, Jean-Louis Schlienger, Jean‐Frédéric Blickle	99
15	Danazol therapy in patients with chronic idiopathic thrombocytopenic purpura: long-term results 2004 ·The American Journal of Medicine ·Frédéric Maloisel, Emmanuel Andrès, Jacques Zimmer, Esther Noël, Alina D. Zamfir, (unknown), P. Dufour	74
16	Prognostic factors of hematological recovery in life-threatening nonchemotherapy drug-induced agranulocytosis 2004 ·La Presse Médicale ·Frédéric Maloisel, Emmanuel Andrès, Georges Kaltenbach, Esther Noël, Catherine Martin‐Hunyadi, P. Dufour	18
17	Modern management of non-chemotherapy drug-induced agranulocytosis: a monocentric cohort study of 90 cases and review of the literature 2002 ·European Journal of Internal Medicine ·Emmanuel Andrès, Frédéric Maloisel, J.E. Kurtz, Georges Kaltenbach, Martine Alt, J.C. Weber, Jean Sibilia, Jean‐Louis Schlienger, (unknown), Jean‐Marie Brogard, P. Dufour	47
18	Nonchemotherapy drug-induced agranulocytosis in elderly patients: the effects of granulocyte colony-stimulating factor 2002 ·The American Journal of Medicine ·Emmanuel Andrès, J.E. Kurtz, Catherine Martin‐Hunyadi, Georges Kaltenbach, Martine Alt, J.C. Weber, Jean Sibilia, Jean‐Louis Schlienger, P. Dufour, Frédéric Maloisel	31
19	Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenström macroglobulinemia in first relapse or with primary refractory disease 2001 ·Blood ·Véronique Leblond, Vincent Lévy, Frédéric Maloisel, Bruno Cazin, Jean‐Paul Fermand, Jean‐Luc Harousseau, (unknown), Raphaël Porcher, Martine Gardembas, Gérald Marit, Éric Deconinck, B Desablens, François Guilhot, G Philippe, Aspasia Stamatoullas, (unknown)	71
20	Idarubicin and High Dose Cytarabine: A New Salvage Treatment for Refractory or Relapsing Non-Hodgkin's Lymphoma 1996 ·Leukemia & lymphoma ·P. Dufour, (unknown), (unknown), T. Lamy, (unknown), Raoul Herbrecht, Frédéric Maloisel, B. Audhuy, Bruno Lioure, (unknown), P Hurteloup, F Oberling	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact